MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

WaferGen Bio-systems Company Profile (NASDAQ:WGBS)

Consensus Ratings for WaferGen Bio-systems (NASDAQ:WGBS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (863.86% upside)

Analysts' Ratings History for WaferGen Bio-systems (NASDAQ:WGBS)
Show:
DateFirmActionRatingPrice TargetActions
3/14/2016Ladenburg ThalmannLower Price TargetBuy$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2015Brean CapitalReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for WaferGen Bio-systems (NASDAQ:WGBS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/10/2016Q1($0.23)($0.24)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q4($0.29)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q315($0.61)($0.61)$2.00 million$2.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.65)($0.67)$2.10 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015($0.56)($0.62)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q314($1.32)$1.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for WaferGen Bio-systems (NASDAQ:WGBS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for WaferGen Bio-systems (NASDAQ:WGBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for WaferGen Bio-systems (NASDAQ:WGBS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/24/2015Awm Investment Company, Inc.Major ShareholderSell505,282$2.10$1,061,092.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2015Awm Investment Company, Inc.Major ShareholderSell492,373$2.31$1,137,381.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for WaferGen Bio-systems (NASDAQ:WGBS)
DateHeadline
06/17/16 09:55 AMWaferGen Bio-Systems (WGBS) Receives USPTO Notice of Allowance Related to SmartChip, ICELL8 Methods
06/16/16 08:33 AMWaferGen Bio-Systems (WGBS) Receives USPTO Notice of Allowance Related to SmartChip, ICELL8 Methods - StreetInsider.com
06/16/16 07:39 AMWaferGen Receives Notice of US Patent Allowance for SmartChip™ and ICELL8™ Single-Cell Methods and Systems to Process Genetic Material from Multi-well Arrays - [at noodls] - FREMONT, Calif., June 16, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent ...
06/08/16 10:26 AMReview of Price Trends: AMN Healthcare Services Inc (NYSE:AHS) , WaferGen Bio-systems, Inc. (NASDAQ:WGBS) - Street Updates
06/06/16 07:25 PMWaferGen Bio-Systems (WGBS) Inks Distribution Deal with Takara Bio in Japan - StreetInsider.com
06/01/16 01:08 PMWaferGen Bio-systems, Inc. :WGBS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 -
05/27/16 01:23 PMLatest Analyst Ratings For WaferGen Bio-systems, Inc. (WGBS) - Share Trading News - Latest Analyst Ratings For WaferGen Bio-systems, Inc. (WGBS)Share Trading NewsWaferGen Bio-systems, Inc. has a 50 day moving average of 0.68 and a 200 day moving average of 0.70. The stock's market capitalization is 18.57M, it has a 52-week low of 0.46 and a 52-week high of 4.53. The share price of the company (WGBS) was up ...
05/26/16 03:09 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a -
05/26/16 12:26 PMNotable Two Stocks to Monitor: WaferGen Bio-systems, Inc. (NASDAQ:WGBS) , Sangamo BioSciences, Inc. (NASDAQ ... - Street Updates - Street UpdatesNotable Two Stocks to Monitor: WaferGen Bio-systems, Inc. (NASDAQ:WGBS) , Sangamo BioSciences, Inc. (NASDAQ ...Street UpdatesWaferGen Bio-systems, Inc. (NASDAQ:WGBS) accumulated +7.0644%, closing at $0.9851 after floating between $0.9400 and $1.0299. The company has market capitalization of $18.47M. It has twelve month low of $0.4600 and twelve month high of $4.5300.and more »
05/13/16 05:15 AMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement -
05/13/16 02:18 AMWaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement - [at noodls] - FREMONT, Calif. and MOUNTAIN VIEW, Calif., May 13, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a publicly held genomics technology company ('WaferGen'), and Takara Bio USA Holdings, ...
05/10/16 03:28 PMWaferGen Bio-systems Reports Results for First Quarter 2016 - [at noodls] - FREMONT, Calif., May 10, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a life sciences company focused on developing and commercializing technology platforms for genomic solutions, announced ...
05/10/16 06:07 AMQ1 2016 WaferGen Bio-systems Inc Earnings Release - After Market Close -
05/03/16 04:23 PMWaferGen Bio-systems Announces ICELL8™ Single-Cell System Placements at the European Molecular Biology Laboratory and Karolinska Institutet - [GlobeNewswire] - Top-tier European Institutions to Utilize ICELL8 System for Stem Cell and Neuroscience Research. FREMONT, Calif. and LUXEMBOURG, May 03, 2016-- WaferGen Bio-systems announced today that the European Molecular ...
05/03/16 07:00 AMWaferGen Bio-systems to Report First Quarter 2016 Financial Results on Tuesday, May 10 - [GlobeNewswire] - FREMONT, Calif., May 03, 2016-- WaferGen Bio-systems, Inc., a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today that it ...
03/28/16 11:09 AMWaferGen Bio-systems, Inc. :WGBS-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/25/16 03:06 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 10-K, Annual Report -
03/09/16 03:13 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E -
02/17/16 07:00 AMWaferGen Announces Key Findings From Collaborators Utilizing Company’s ICELL8™ Single-Cell System at AGBT 2016 General Meeting - [GlobeNewswire] - FREMONT, Calif., Feb. 17, 2016-- WaferGen Bio-systems, a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today results from ...
02/16/16 03:13 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement -
02/14/16 01:50 PMWaferGen Bio-systems, Inc. (WGBS) - WAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, FinanEDGAR Online (Wed, Oct 21)
02/09/16 07:00 AMWaferGen Announces ICELL8™ Single-Cell System Collaborators to Present Key Results at AGBT 2016 General Meeting - [GlobeNewswire] - FREMONT, Calif., Feb. 09, 2016-- WaferGen Bio-systems, a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today that three oral ...
02/05/16 01:54 PMWaferGen Bio-Systems Announces Collaboration With BloodCenter Of Wisconsin For High Throughput Molecular ... - Laboratory Network - WaferGen Bio-Systems Announces Collaboration With BloodCenter Of Wisconsin For High Throughput Molecular ...Laboratory NetworkFremont, CA and Milwaukee, WI (GLOBE NEWSWIRE) - WaferGen Bio-systems (NASDAQ:WGBS) announced today that the Company has signed a supply agreement with BloodCenter of Wisconsin (BCW), a not-for-profit organization that specializes in ...
02/03/16 01:21 PMLatest Analysts Reports On WaferGen Bio-systems, Inc. (WGBS) - Risers & Fallers - Latest Analysts Reports On WaferGen Bio-systems, Inc. (WGBS)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of WaferGen Bio-systems, Inc. (WGBS). The latest broker reports which have been released state 1 analyst has a rating of “buy”, 0 analysts “outperform”, 0 analysts “hold”, ...
02/02/16 01:28 PMWaferGen Bio-Systems (WGBS), BloodCenter of Wisconsin Enter Blood Typing Collaboration - StreetInsider.com - WaferGen Bio-Systems (WGBS), BloodCenter of Wisconsin Enter Blood Typing CollaborationStreetInsider.comWaferGen Bio-systems (Nasdaq: WGBS) announced that the Company has signed a supply agreement with BloodCenter of Wisconsin (BCW), a not-for-profit organization that specializes in blood services, diagnostic testing, organ, tissue and marrow ...WaferGen Bio-systems Announces Collaboration With BloodCenter of Wisconsin for High Throughput Molecular Blood ...EconoTimesall 4 news articles »
02/02/16 07:03 AM8:03 am WaferGen Bio-Systems signs a supply agreement with BloodCenter of Wisconsin -
02/02/16 07:00 AMWaferGen Bio-systems Announces Collaboration With BloodCenter of Wisconsin for High Throughput Molecular Blood Typing - [GlobeNewswire] - FREMONT, Calif. and MILWAUKEE, Feb. 02, 2016-- WaferGen Bio-systems announced today that the Company has signed a supply agreement with BloodCenter of Wisconsin, a not-for-profit organization that specializes ...
02/01/16 01:13 PMCompany Shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) Rally 15.62% - Market Briefing - Company Shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) Rally 15.62%Market BriefingShares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) appreciated by 15.62% during the past week but lost 11.42% on a 4-week basis. The shares have outperformed the S&P 500 by 13.63% in the past week but underperformed the index by 6.69% in the ...
01/28/16 01:06 PMWaferGen Bio-systems Announces 50 Percent Year-Over-Year Growth in Fourth Quarter 2015 Revenues - GlobeNewswire (press release) - WaferGen Bio-systems Announces 50 Percent Year-Over-Year Growth in Fourth Quarter 2015 RevenuesGlobeNewswire (press release)FREMONT, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- WaferGen Bio-systems (NASDAQ:WGBS) today announced preliminary, unaudited revenue for the fourth quarter of 2015. The Company expects total revenue for the fourth quarter of 2015 to be in the ...and more »
01/28/16 07:00 AMWaferGen Bio-systems Announces 50 Percent Year-Over-Year Growth in Fourth Quarter 2015 Revenues - [GlobeNewswire] - Fourth Quarter Revenues Include Initial Two ICELL8™ Single-Cell System Sales and Represents 15-25% Growth Over Third Quarter 2015 Revenues. Company Provides Full-Year 2016 Revenue Guidance; Expecting 70 ...
01/26/16 01:11 PMWaferGen Bio-systems, Inc. Analyst Rating Update - Market Briefing - WaferGen Bio-systems, Inc. Analyst Rating UpdateMarket BriefingWaferGen Bio-systems, Inc. (NASDAQ:WGBS) has received a buy rating for the short term, according to the latest rank of 2 from research firm, Zacks Investment Research. The company received an average rating of 1 from 1 analysts. 1 have rated it as a ...
01/25/16 12:27 PMCompany Shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) Drops by -0.07% - The Daily Rover - Company Shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) Drops by -0.07%The Daily RoverWaferGen Bio-systems, Inc. (NASDAQ:WGBS) has lost 0.07% during the past week and dropped 28.44% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 1.46%. WaferGen Bio-systems, Inc.
01/19/16 06:50 PMWafergen Bio-Systems Inc Bullish Trade Empery Asset Management increased Its ... - fdanewsalert.com - Wafergen Bio-Systems Inc Bullish Trade Empery Asset Management increased Its ...fdanewsalert.comEmpery Asset Management filed with SEC a SC 13G/A form about Wafergen Bio-Systems, Inc. The form can be accessed here: 000090266416004875. As reported by Empery Asset Management, the filler increased its stake in the stock by 10.71% for 560,000 ...and more »
01/17/16 06:44 PMFeatured Stock: WaferGen Bio-systems, Inc - iStreetWire - Featured Stock: WaferGen Bio-systems, InciStreetWireThe shares of WaferGen Bio-systems, Inc. (NASDAQ:WGBS) had been given positive outlook from Sell-side analysts. Based on the poll results published by the Zacks Research, the stock of the company has been assigned a 1.00 rating. The rating score is on ...
12/29/15 01:00 PMWaferGen Fails to Satisfy Nasdaq Norms: Will it be Delisted? -
12/28/15 03:05 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or -
12/21/15 04:37 PMWaferGen Bio-systems Announces First Commercial Sale of ICELL8(TM) Single-Cell System to Major Global Pharmaceutical Company - [at noodls] - System Now Fully Functional in Customer's Lab FREMONT, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) today announced the first commercial sale of WaferGen's ICELL8™ ...
12/21/15 04:37 PMWaferGen Bio-systems Announces Publication of BGI Data in GigaScience Demonstrating Utility of WaferGen’s ICELL8™ Technology for Single-Cell Analysis in Cancer Research - [at noodls] - FREMONT, Calif., Dec. 17, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) announced today that single-cell analysis results generated by BGI utilizing WaferGen's ICELL8™ single-cell technology ...
12/16/15 12:40 PMWaferGen Collaborates with LIH for ICELL8 Single-Cell System -
12/14/15 05:23 PMWaferGen Bio-systems and Luxembourg Institute of Health Collaborate to Support Introduction of ICELL8™ Single-Cell System to European Medical Researchers - [PR Newswire] - FREMONT, Calif. and LUXEMBOURG, Dec. 14, 2015 /PRNewswire/ -- WaferGen Bio-systems (WGBS) announced today that the Company has signed a collaboration agreement with the Luxembourg Institute of Health (LIH), a leading public medical research center that specializes in oncology, infectious diseases, immunology, and population health. LIH will provide laboratory facilities for the ICELL8™ Single-Cell System and use of its state-of-the art cell culture, genomics and proteomics facilities. The agreement will allow European researchers to evaluate the system, which can also be used to support LIH research programs. The ICELL8 Single-Cell System is a revolutionary platform which can isolate thousands of single cells and process specific cells of interest for downstream analysis using Next Generation Sequencing.
12/08/15 12:18 PMWAFERGEN BIO-SYSTEMS, INC. Financials -
12/01/15 10:27 AMWaferGen Bio-systems, Inc. Earnings Q3, 2015 -
11/12/15 04:49 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report -
11/12/15 08:40 AMWaferGen (WGBS) Q3 Loss Narrows, Revenues Improve Y/Y -
11/10/15 03:04 PMWAFERGEN BIO-SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an -
11/10/15 03:01 PMWaferGen Bio-systems Reports Results for Third Quarter 2015 - [PR Newswire] - FREMONT, Calif., Nov. 10, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NasdaqCM: WGBS) announced today its financial results for the third quarter and nine months ended September 30, 2015. Key Recent ...
About WaferGen Bio-systems

WaferGen Bio-systems logoWaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: WGBS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.83
  • 50 Day Moving Average: $0.83
  • 200 Day Moving Average: $0.70
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $15.56M
  • Current Quarter EPS Consensus Estimate: $-0.73 EPS
Additional Links:
WaferGen Bio-systems (NASDAQ:WGBS) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha